martes, 9 de febrero de 2010

Pfizer: "Apenados por el pene" al fin les reconocen...


Estaban (Pfizer) "apenados" por el problema del pene y... "buscaron remedio", fuera porque en "casa" no había...


Lo lograron...

Se lo reconocieron...

Al fin y al cabo..."Extensión de línea".



The FDA today approved Auxilium´s Xiaflex drug for Dupuytren’s contracture. Or, to translate that into language a layperson would be interested in: The FDA today approved Pfizer´s penis-straightening drug for a related condition, claw-hand.


BNET readers will remember thatPfizer entered a $75 million pact with Auxilium for the development of Xiaflex in December 2008. And while the pair are developing the compound for use to combatDupuytren’s contracture (where patients’ hands contract into claws), everyone knows that theother potential use Xiaflex has is for Peyronie’s disease, or curvature of the penis from a buildup of fibrous tissue in the shaft. You can see Auxilium has a trial ongoing here, and the drug in question, “AA4500,” is the same as that used in the Xiaflex trials here.

With the drug now heading to market, the question now is how much of the drug’s sales will be for the off-label Peyronie’s indication? I’m betting not much: Even though the drug works in
straightening rats’ tails it must still be administered by injection at the site of the organ, and that can
cause bruising.

Mas...

No hay comentarios: